mint Lesion™ 1.8

mint Lesion™ 1.8 Announcement: Dedicated workflows to manage lymphoma patients in trials and clinical routine

In time for RSNA 2011 Mint Medical GmbH announced the new mint Lesion™ 1.8. This feature release puts strong focus on the assessment of lymphoma patients. It comes with elaborate support for the Cheson 2007 response criteria, including assessment of metabolic FDG-PET imaging data. Furthermore, the possibility to assess nodules, bone marrow involvement and relevant organs, like spleen and liver, is seamlessly integrated in our streamlined working concept.

Do not hesitate to contact us for your personal demonstration on how mint Lesion™ 1.8 can leverage your workload in oncological radiology.